Skip to main content
. 2023 Aug 10;34(10):1733–1751. doi: 10.1681/ASN.0000000000000189

Table 4.

List of nonserious adverse events

Adverse Event Type ORBCEL-M
Events, n (Participants, n)
Placebo
Events, n (Participants, n)
Left bundle block 2 (2)
First-degree atrioventricular block 1 (1)
Inferior Q wave 1 (1)
Ejection systolic murmur 1 (1)
Chest pain 2 (2)
Fatigue 1 (1)
Asthenia 1 (1)
Increased edema 4 (1)
Hypoglycemia 1 (1)
Eye disorder 1 (1)
Cataract 1 (1)
Diarrhea 3 (3) 1 (1)
Heartburn 1 (1)
Vomiting associated with ileus 1 (1)
Hemorrhoids 1 (1)
Fever of unknown origin 1 (1)
Flu-like syndrome 1 (1)
Ankle swelling 1 (1)
Bruised ribs 1 (1)
Stenosing tenosynovitis 1 (1)
Laceration to left shin 1 (1)
Left knee swelling 1 (1)
Traumatic injury left foot 1 (1)
Fall 1 (1)
Meralgia paresthetica 1 (1)
Wound infection 1 (1)
Pain associated with SAE hip fracture 1 (1)
Pain right heel 1 (1)
Knee pain 1 (1)
Painful shoulder 1 (1)
Headache 1 (1)
Low mood 1 (1)
Memory impairment 1 (1)
Disoriented 1 (1)
Cough 2 (2) 1 (1)
Hoarse 1 (1)
Obstructive sleep apnea 1 (1)
Abdominal bruising 1 (1)
Perianal dermatitis 1 (1)
Pressure sore (sacral) 1 (1)
Tingling in limb peripheries 1 (1)
Benign prostatic hyperplasia 1 (1)
Secondary hyperparathyroidism 1 (1)
Erythroderma 1 (1)
Urinary tract infection 1 (1)
AKI 1 (1)
Hypereosinophilia 1 (1)
Total 45 (11) 12 (4)

SAE, serious adverse event.